Table II.
Experimental conditions and results.
| Treatment combination | Ester ClSi reaction time (h) | Grafting reaction time (h) | CuBr2 (mg cm−2) | Vitamin C (mg cm−2) | Covariatea | Replicate 1 | Replicate 2 | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| A | B | C | D | ||||||||
| (1)b | −1 | (24) | −1 | (24) | −1 | (1) | −1 | (79) | 1 | 1.11 | 0.17 |
| A | 1 | (72) | −1 | (24) | −1 | (1) | −1 | (79) | −1 | 0.00 | 0.09 |
| B | −1 | (24) | 1 | (72) | −1 | (1) | −1 | (79) | −1 | 2.29 | 3.55 |
| AB | 1 | (72) | 1 | (72) | −1 | (1) | −1 | (79) | 1 | 1.21 | 0.18 |
| C | −1 | (24) | −1 | (24) | 1 | (2) | −1 | (79) | −1 | 0.00 | 0.00 |
| AC | 1 | (72) | −1 | (24) | 1 | (2) | −1 | (79) | 1 | 1.15 | 0.12 |
| BC | −1 | (24) | 1 | (72) | 1 | (2) | −1 | (79) | 1 | 0.64 | 2.34 |
| ABC | 1 | (72) | 1 | (72) | 1 | (2) | −1 | (79) | −1 | 0.22 | 1.87 |
| D | −1 | (24) | −1 | (24) | −1 | (1) | 1 | (158) | −1 | 0.48 | 0.43 |
| AD | 1 | (72) | −1 | (24) | −1 | (1) | 1 | (158) | 1 | 1.16 | 0.18 |
| BD | −1 | (24) | 1 | (72) | −1 | (1) | 1 | (158) | 1 | 0.62 | 2.46 |
| ABD | 1 | (72) | 1 | (72) | −1 | (1) | 1 | (158) | −1 | 0.00 | 1.15 |
| CD | −1 | (24) | −1 | (24) | 1 | (2) | 1 | (158) | 1 | 0.76 | 1.44 |
| ACD | 1 | (72) | −1 | (24) | 1 | (2) | 1 | (158) | −1 | 0.00 | 1.09 |
| BCD | −1 | (24) | 1 | (72) | 1 | (2) | 1 | (158) | −1 | 0.00 | 0.36 |
| ABCD | 1 | (72) | 1 | (72) | 1 | (2) | 1 | (158) | 1 | 1.22 | 1.71 |
a
The covariate levels apply to replicate 1 only. The covariate level was 1 (analyzer angle of 0°) throughout replicate 2.
b
The treatment combination “(1)” is where low (−1) levels are used for all factors. See Table I for these experimental conditions.